Skip to search formSkip to main contentSkip to account menu

Aspergillus chevalieri

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Metabolomics and Dereplication Study of the Endophytic Fungus Aspergillus chevelieri in Search of Bioactive Natural Compounds
Objectives: This study aimed to point the significant rule of metabolomics tools to assess the chemistry of the bioactive… 
2014
2014
Amylase activity in culture filtrate of Aspergillus chevalieri
This study was carried out to determine the growth and production of amylase by Aspergillus chevalieri in a defined medium. A… 
Highly Cited
2000
Highly Cited
2000
Effect of Sitophilus zeamais and Aspergillus chevalieri on the oxygen level in maize stored hermetically
1994
1994
Aspergillus chevalieri (Mangin) Thom and Church: a new opportunistic pathogen of human cutaneous aspergillosis
Three cases of opportunistic cutaneous aspergillosis caused by Aspergillus chevalieri are described. The lesions were… 
1992
1992
Toxicity and mutagenicity of anthraquinones from Aspergillus chevalieri.
More than 100 strains of the Aspergillus glaucus group were cultivated on synthetic media for 11 days at 28 degrees C. Organic… 
1989
1989
Toxicity of echinulin from Aspergillus chevalieri in rabbits.
1979
1979
Toxicity and mutagenicity of molds of the Aspergillus glaucus group. Identification of physcion and three related anthraquinones as main toxic constituents from Aspergillus chevalieri.
1976
1976
Structure of a New Metabolite from Aspergillus chevalieri
A new metabolite has been isolated from Aspergillus chevalieri as colorless needles, mp 294–296°C, [α]d + 46°. It has a… 
1975
1975
Studies on induced reversions at the arginine locus of Aspergillus chevalieri (Mangin).
1967
1967
Studies on induced mutation in aspergillus chevalieri
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)